Hilliard Lyons upgraded National Health Investors (NYSE: NHI) from Neutral to Long-Term Buy (from $77.00).Analyst John Roberts comments "While rising ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE